Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
J Neuroimaging ; 20(4): 311-23, 2010 Oct.
Article in English | MEDLINE | ID: mdl-19344369

ABSTRACT

The so-called "crowned dens" is a peculiar manifestation of calcium crystal deposition diseases, either caused by calcium pyrophosphate dihydrate or caused by calcium hydroxiapatite crystals, characterized by the presence of calcific deposits around the odontoid, often showing a crown-like configuration on imaging. It has protean clinical and radiological pictures, and care should be taken to avoid misinterpretation and diagnostic errors. Although asymptomatic in many patients, this entity may present as a predominantly algic or febrile condition, and in some cases, signs of compression of the spinal cord may be the major complaint. The detection of calcifications in the periodontoid tissues is the key to the diagnosis, erosive osseous changes, and variably calcified soft-tissue masses being occasionally associated. Computed tomography is the most important imaging study to be performed in this setting.


Subject(s)
Calcinosis/diagnosis , Magnetic Resonance Imaging/methods , Odontoid Process/diagnostic imaging , Odontoid Process/pathology , Spinal Diseases/diagnosis , Tomography, X-Ray Computed/methods , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged
2.
Rio de Janeiro; Guanabara Koogan; 2007. 513 p.
Monography in Portuguese | LILACS | ID: biblio-971434
3.
Skeletal Radiol ; 33(12): 732-6, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15309334

ABSTRACT

Biphosphonates are now being used experimentally in children to increase bone mass, but their long-term effects remain an issue of concern. We report two cases of biphosphonate-induced radiographic changes in children with rheumatic diseases. Our experience supports the view that clinical improvement and radiographic findings after biphosphonate therapy are related to increased bone mineral density, without effects on the inflammatory process itself. Biphosphonates seem to act in rheumatic diseases by reducing bone turnover instead of improving disease activity.


Subject(s)
Alendronate/therapeutic use , Arthritis, Juvenile/drug therapy , Diphosphonates/therapeutic use , Lupus Erythematosus, Systemic/drug therapy , Osteoporosis/diagnostic imaging , Alendronate/pharmacology , Arthritis, Juvenile/diagnostic imaging , Bone Density/drug effects , Bone Remodeling/drug effects , Child , Diphosphonates/pharmacology , Humans , Lupus Erythematosus, Systemic/diagnostic imaging , Male , Osteoporosis/drug therapy , Radiography , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...